Fahad Gul

Fahad Gul

Auto-generated profile, based on publicly available information

Fahad Gul

Department of Medicine, Einstein Medical Center Philadelphia, PA, United States of America

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
RHRaul Hiedra
Raul Hiedra
KLKevin Bryan Lo
Kevin Bryan Lo
MEMohammad Elbashabsheh
Mohammad Elbashabsheh
FGFahad Gul
Fahad Gul
RWRobert Matthew Wright
Robert Matthew Wright
GAGabriel Patarroyo Aponte
Gabriel Patarroyo Aponte
The coronavirus disease 2019 (COVID-19) pandemic has affected almost 2.5 million people worldwide with almost 170 000 deaths reported to date. So far, there is scarce evidence for the current treat...

3 July 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
GSGrace Salacup
Grace Salacup
KLKevin Bryan Lo
Kevin Bryan Lo
FGFahad Gul
Fahad Gul
EPEric Peterson
Eric Peterson
RJRobert De Joy
Robert De Joy
JRJanani Rangaswami
Janani Rangaswami
There is limited information describing the characteristics and clinical outcomes of patients infected with coronavirus disease 2019 (COVID‐19) especially those in underserved urban area with minority population in the United States. This is a retrospective single‐center study for patients who were admitted with COVID‐19 infection. Data collection was from 1 March through 24 April 2020. Demographic, clinical, laboratory, and treatment data were presented using descriptive statistics and frequencies. The χ2 test and multivariate logistic regression were used to determine association of risk factors and clinical outcomes. A total of 242 inpatients were included with a mean age of 66 ± 14.75 (±standard deviation). A total of 50% were female and 70% were African American. Comorbidities included hypertension (74%), diabetes mellitus (49%), and 19% had either COPD or asthma. Older age was associated with higher risk of inpatient death odds ratio (OR): 1.056 (95% confidence interval [CI]: 1.023‐1.090; P = .001). Inpatient mortality occurred in 70% who needed mechanical ventilation (OR: 29.51; 95% CI: 13.28‐65.60; P < .0001), 58% who required continuous renal replacement therapy/hemodialysis (CRRT/HD) (OR: 6.63; 95% CI: 2.74‐16.05; P < .0001), and 69% who needed vasopressors (OR: 30.64; 95% CI: 13.56‐69.20; P < .0001). Amongst biomarkers of disease severity, only baseline CRP levels (145 ± 116 mg/L) were associated with mortality OR: 1.008 (95% CI: 1.003‐1.012; P = .002). Majority of hospitalized patients had hypertension and diabetes. Older age was an independent risk factor for inpatient mortality. Requirement of mechanical ventilation, vasopressor use, and CRRT/HD was associated significantly with inpatient mortality. Higher baseline CRP was significantly associated with inpatient death.

17 August 2020 in Acta Diabetologica
Verified
Journal Article
Open access
PDF file
TFTamaryn Fox
Tamaryn Fox
KRKathleen Ruddiman
Kathleen Ruddiman
KLKevin Bryan Lo
Kevin Bryan Lo
EPEric Peterson
Eric Peterson
RDRobert DeJoy
Robert DeJoy
GPGabriel Patarroyo-Aponte
Gabriel Patarroyo-Aponte
Aims Coronavirus disease 19 (COVID-19) has become a pandemic. Diabetic patients tend to have poorer outcomes and more severe disease (Kumar et al. in Diabetes Metab Syndr 14(4):535–545, 2020. https://doi.org/10.1016/j.dsx.2020.04.044). However, the vast majority of studies are representative of Asian and Caucasian population and fewer represent an African-American population. Methods In this single-center, retrospective observational study, we included all adult patients (> 18 years old) admitted to Einstein Medical Center, Philadelphia, with a diagnosis of COVID-19. Patients were classified according to having a known diagnosis of diabetes mellitus. Demographic and clinical data, comorbidities, outcomes and laboratory findings were obtained. Results Our sample included a total of 355 patients. 70% were African-American, and 47% had diabetes. Patients with diabetes had higher peak inflammatory markers like CRP 184 (111–258) versus 142 (65–229) p = 0.012 and peak LDH 560 (384–758) versus 499 (324–655) p = 0.017. The need for RRT/HD was significantly higher in patients with diabetes (21% vs 11% p = 0.013) as well as the need for vasopressors (28% vs 18% p = 0.023). Only age was found to be an independent predictor of mortality. We found no significant differences in inpatient mortality p = 0.856, need for RRT/HD p = 0.429, need for intubation p = 1.000 and need for vasopressors p = 0.471 in African-Americans with diabetes when compared to non-African-Americans. Conclusions Our study demonstrates that patients with COVID-19 and diabetes tend to have more severe disease and poorer clinical outcomes. African-American patients with diabetes did not differ in outcomes or disease severity when compared to non-African-American patients.

1 June 2021 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
SCShireen R. Chacko
Shireen R. Chacko
RDRobert DeJoy
Robert DeJoy
KLKevin Bryan Lo
Kevin Bryan Lo
JAJeri Albano
Jeri Albano
EPEric Peterson
Eric Peterson
EGEna Gupta
Ena Gupta

2 June 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ARAriel Roguin
Ariel Roguin
PWPerry Wu
Perry Wu
TCTravis Cohoon
Travis Cohoon
FGFahad Gul
Fahad Gul
GNGeorge Nasr
George Nasr
MKMorton J. Kern
Morton J. Kern
Radiation exposure in the cardiac catheterization laboratory (CCL) is an occupational hazard that predisposes health care workers to the development of adverse health effects such as cataracts, cancer, and orthopedic injury. To mitigate radiation exposure, personal protective shielding as well as permanently installed shields reduces these adverse effects. Yet, heavy protective lead aprons and poor ergonomics required for positioning movable shields remain barriers to a safer environment. Recent innovations to enhance personal protective equipment and revolutionize fixed shielding systems will permit the CCL team to work in a personal “lead-free” environment, markedly reducing occupational hazards. The purpose of this review is to update the status and future of radiation protection in the CCL.

29 May 2020 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
FGFahad Gul
Fahad Gul
KLKevin Bryan Lo
Kevin Bryan Lo
JPJulie Peterson
Julie Peterson
Peter A McCulloughPeter A McCullough
Peter A McCullough
AGAbhinav Goyal
Abhinav Goyal
JRJanani Rangaswami
Janani Rangaswami
This systematic review analyzed whether the presence or absence of gastrointestinal symptoms in patients with SARS-COV-2 infection is associated with adverse outcomes. Searching the Cochrane Center Register of Controlled Trials, we included any studies looking at patients with COVID-19 with gastrointestinal symptoms (nausea, vomiting, diarrhea, abdominal pain) compared to those with COVID-19 but without gastrointestinal manifestations as a control group. The final search yielded 186 articles, all of which were individually screened. Seven studies were identified but three were excluded: one due to lack of a control group without gastrointestinal symptoms, one reported as viral RNA in the stool, and one with only non-critically ill patients. Results of the meta-analysis showed a pooled odds ratio for mortality among those with COVID-19 and gastrointestinal symptoms of 0.91 (confidence interval 0.49–1.68) with heterogeneity of 0% and a pooled odds ratio for acute respiratory distress syndrome of 2.94 (confidence interval 1.17–7.40) with heterogeneity of 0%. In conclusion, gastrointestinal symptoms with COVID-19 are associated with a higher risk of acute respiratory distress syndrome, but do not increase the risk for mortality.